General Archive
-
ArticlesThe new LifeArc identity: More than just a fresh coat of paint
In the world of medical research, it’s vital that we keep challenging ourselves to push forwards. We’ve created a new…
-
News releasesNew partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development
LifeArc and ALS Therapy Development Institute (ALS TDI) have joined forces to identify, validate, and develop new biomarkers that are…
-
News releasesLifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation
LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London (KCL) to validate a…
-
News releasesLifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR)
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR), which was published today, highlighting the desperate need…
-
ArticlesLifeArc Translational Science Summit: Highlights and key takeaways
The first ever LifeArc Translational Science Summit was a resounding success! Held on 23 April in London, the event brought…
-
News releasesFirst-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Great Ormond Street Hospital (GOSH), supported by LifeArc and Great Ormond Street Hospital Children’s Charity (GOSH Charity), is announcing its…
-
News releasesLifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership
The Crick Africa Network (CAN), a partnership between LifeArc, the Francis Crick Institute and 5 African institutions, has now awarded…
-
News releasesLifeArc signs statement calling for the UK to lead the G7 on R&D investment
The Campaign for Science and Engineering (CaSE) has released a joint statement urging all political parties to commit the UK…
-
News releasesLifeArc funds pivotal clinical trial to treat an ultra-rare genetic disease with possible link to leader of the mutiny on the Bounty in 1789
A pivotal clinical trial to look at repurposing the UK-licensed medicine, deferiprone, for patients with neuroferritinopathy, an ultra-rare genetic disease…
-
News releasesReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
ReAct (Action on Antibiotic Resistance) Africa, in partnership with self-funded medical research organisation and charity LifeArc, is excited to introduce…
-
News releasesLifeArc joins £20m international project to develop novel cancer treatment for children
LifeArc is investing up to £4.9 million to bolster a joint international project to create new cancer therapies specifically for…
-
Articles6 challenges in rare disease research and how we can overcome them
Rare conditions, individually, have low patient numbers. However, with more than 7,000 rare diseases identified, collectively there are millions of…